Access to Breakthroughs
As America's Baby Boomer turn 65 at a record pace, it's imperative that policymakers reinvest in the FDA. Through its work with the Alliance for a Stronger FDA and the Leadership Council of Aging Organizations, and as the leader of the ACT-AD Coalition, the Alliance stresses the importance of safe and quick access to breakthrough treatments for aging-related diseases and conditions such as Alzheimer's, cancer, cardiovascular diseases, and arthritis.
Position & Issues
Related Events
-
One Year Later: FDASIA and its Impact for Diseases of Aging
September 17th, 2013, Washington, DC
Related Publications
-
Press ReleaseGrowing Burden of Persistent Pain Calls for More Medical Innovation
February 20, 2013
Related topics: Access to Breakthroughs Aging Research Cancer Federal Funding Health Medical Innovation Persistent Pain Policy ResearchCynthia Bens, Alliance for Aging Researchcbens@agingresearch.org, 202-293-2856
Penney Cowan, American Chronic Pain Assoc.pcowan@tehacpa.org, 916-632-0922
Nicole Grady, American Osteopathic Assoc.
ngrady@osteopathic.org, 312-202-8038
Paul Gileno, US Pain Foundation
uspainfoundation@gmail.com, 860-788-6062
Washington, D.C. – Today, the Alliance for Aging Research released a new volume of The Silver Book®: Chronic Disease and Medical Innovation in an Aging Nation. This latest addition to The Silver Book series paints a comprehensive picture of the burden of persistent pain, and the value of innovation that helps reduce that burden. The briefing--held in partnership with the American Chronic Pain Association, the American Osteopathic Association, and the US Pain Foundation--featured a medical expert, a pain patient, and leaders from the partnering organizations.
-
Get Mad ColumnHelping Stop a Devastating Disease: The ACT-AD Coalition Continues its Important Work in Alzheimer's
Winter 2013
Related topics: Access to Breakthroughs Alzheimer's Disease Drug Development Health PolicyAlzheimer's disease is a slow, dehumanizing, and fatal disease that strikes 1 in 8 people over the age of 65. While it's typically thought of as a disease that affects memory, it goes well beyond memory loss and eventually leads to death. -
Science in the SpotlightMuscle Loss & Aging: Combatting Sarcopenia and Lost Independence
Winter 2013 | Alliance for aging Research
Related topics: Access to Breakthroughs Aging Research Drug Development Geriatric Training HealthTypically, our muscles grow larger and stronger as we age. That is, until about the time we celebrate our 30th birthdays. That’s when most of us start down the other side of the hill and begin to gradually lose our muscle mass, strength, and function. While it’s usually not very noticeable in our 30s and 40s, the loss increases exponentially with age and tends to accelerate between the ages of 65 and 80.
This progressive loss of muscle mass is called sarcopenia, and it’s found to play a major role in the increased frailty, disability, and functional impairment that too often come with aging. While sarcopenia is a condition that is not uncommon with age, we don’t have to just sit back and accept it. There are things we can do to slow its progress, and current research promises to make that trip over-the-hill less traumatic.
